サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421669

がん生検市場、シェア、規模、動向、産業分析レポート：製品タイプ別、用途別、地域別、セグメント別予測、2024年～2032年

Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
がん生検市場、シェア、規模、動向、産業分析レポート：製品タイプ別、用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界のがん生検市場規模は2032年までに920億9,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

生検は、病気を発見するために体のあらゆる部分から組織を採取する医療処置です。針による採取や手術による採取など、さまざまな方法が用いられます。MRIやCTスキャンなどの画像検査で異常を特定することはできるが、がん細胞と非がん細胞を区別することはできないです。したがって、生検は悪性腫瘍の診断を確定するために不可欠であり、詳細な細胞分析を伴う。

体液生検の進歩ががん生検市場の成長に大きく影響しています。この革新的な技術は血流中の遺伝物質を分析し、非侵襲的なアプローチで特定のがん種の検出とモニタリングを可能にします。

生検は、さまざまながん種の生物学的性質に関する重要な洞察を提供します。この情報は、潜在的な創薬標的を同定し、新しい治療法を評価するための臨床試験を計画する上で有用です。生検はまた、治療反応のモニタリングや耐性メカニズムの同定にも用いられ、より効果的な薬剤や併用療法の開発に貢献しています。

がん生検市場は多くの課題に直面しています。高度な生検技術や分子プロファイリング技術は、資源が限られている地域では容易に利用できないです。さらに、複雑なゲノムデータの解釈には専門的な知識が必要であり、腫瘍学における継続的な教育とトレーニングの必要性が浮き彫りになっています。侵襲的な生検手技は患者に不快感を与え、この手技を受けたがらないことにつながります。さらに、生検手順や関連技術のコストは、個人や医療システムによっては高すぎることもあります。質の高い生検サービスへの平等なアクセスを確保し、がん診断と治療に最大限の効果をもたらすためには、これらの課題を克服することが不可欠です。

がん生検市場レポートハイライト

  • リキッド生検分野は、幅広い利用により予測期間中に最も高いCAGRで成長すると予想されます。
  • キットと消耗品セグメントは2022年に最大の市場シェアを占めたが、これは主に費用対効果と高い性能によるものです。
  • 乳がん分野は2022年に大きな市場収益シェアを占めたが、これは主にその高い有病率による。
  • 北米地域が2022年に市場の大半を占め、その大半のシェアを占める。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のがん生検市場別洞察

  • がん生検市場-用途のスナップショット
  • がん生検市場力学
    • 促進要因と機会
      • がん患者の増加により製品需要が刺激されると予測される
      • 分子診断法の進歩
    • 抑制要因と課題
      • がん生検検査に関連する高額な費用
  • PESTEL分析
  • がん生検市場の用途動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のがん生検市場、タイプ別

  • 主要調査結果
  • イントロダクション
  • 体液生検
  • 組織生検
  • その他

第6章 世界のがん生検市場、製品タイプ別

  • 主要調査結果
  • イントロダクション
  • キットと消耗品
  • 装置
  • サービス

第7章 世界のがん生検市場、用途別

  • 主要調査結果
  • イントロダクション
  • 乳がん
  • 子宮頸がん
  • 肺がん
  • 結腸直腸がん
  • その他

第8章 世界のがん生検市場、地域別

  • 主要調査結果
  • イントロダクション
    • がん生検市場評価、地域別、2019～2032年
  • がん生検市場-北米
    • 北米：がん生検市場、タイプ別、2019～2032年
    • 北米：がん生検市場、用途別、2019～2032年
    • 北米：がん生検市場、製品タイプ別、2019～2032年
    • がん生検市場-米国
    • がん生検市場-カナダ
  • がん生検市場-欧州
    • 欧州：がん生検市場、タイプ別、2019～2032年
    • 欧州：がん生検市場、用途別、2019～2032年
    • 欧州：がん生検市場、製品タイプ別、2019～2032年
    • がん生検市場-英国
    • がん生検市場-フランス
    • がん生検市場-ドイツ
    • がん生検市場-イタリア
    • がん生検市場-スペイン
    • がん生検市場-オランダ
    • がん生検市場-ロシア
  • がん生検市場-アジア太平洋
    • アジア太平洋：がん生検市場、タイプ別、2019～2032年
    • アジア太平洋：がん生検市場、用途別、2019～2032年
    • アジア太平洋：がん生検市場、製品タイプ別、2019～2032年
    • がん生検市場-中国
    • がん生検市場-インド
    • がん生検市場-マレーシア
    • がん生検市場-日本
    • がん生検市場-インドネシア
    • がん生検市場-韓国
  • がん生検市場-中東・アフリカ
    • 中東・アフリカ：がん生検市場、タイプ別、2019～2032年
    • 中東・アフリカ：がん生検市場、用途別、2019～2032年
    • 中東・アフリカ：がん生検市場、製品タイプ別、2019～2032年
    • がん生検市場-サウジアラビア
    • がん生検市場-アラブ首長国連邦
    • がん生検市場-イスラエル
    • がん生検市場-南アフリカ
  • がん生検市場-ラテンアメリカ
    • ラテンアメリカ：がん生検市場、タイプ別、2019～2032年
    • ラテンアメリカ：がん生検市場、用途別、2019～2032年
    • ラテンアメリカ：がん生検市場、製品タイプ別、2019～2032年
    • がん生検市場-メキシコ
    • がん生検市場-ブラジル
    • がん生検市場-アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
図表

List of Tables

  • Table 1 Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 19 UK: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 22 France: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 43 China: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 46 India: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Biopsy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Cancer Biopsy Market, by Product Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Cancer Biopsy Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Cancer Biopsy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cancer Biopsy Market
目次
Product Code: PM4004

The global cancer biopsy market size is expected to reach USD 92.09 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A biopsy is a medical procedure that involves extracting tissue from any part of the body to detect diseases. Different methods, including needle-based or surgical extraction, are used. Imaging tests such as MRIs and CT scans can identify abnormalities, but they cannot differentiate between cancerous and non-cancerous cells. Therefore, biopsies are essential to confirm malignancy diagnoses and involve detailed cellular analysis.

Advancements in liquid biopsies have significantly influenced the growth of the cancer biopsy market. This innovative technique analyzes genetic material in the bloodstream, making it possible to detect and monitor specific cancer types in a non-invasive approach.

Biopsies offer crucial insights into the biology of different cancer types. This information is instrumental in identifying potential drug targets and designing clinical trials to evaluate new therapies. Biopsies are also used to monitor treatment response and identify mechanisms of resistance, contributing to the development of more effective drugs and combination therapies.

The cancer biopsy market is facing numerous challenges. Advanced biopsy techniques and molecular profiling technologies are not readily available in areas with limited resources. Additionally, interpreting complex genomic data requires specialized expertise, which highlights the need for ongoing education and training in oncology. Invasive biopsy procedures can cause discomfort to patients, leading to reluctance to undergo the process. Moreover, the cost of biopsy procedures and related technologies can be too high for some individuals and healthcare systems. It is vital to overcome these challenges to ensure equal access to high-quality biopsy services and to maximize their impact on cancer diagnosis and treatment.

Cancer Biopsy Market Report Highlights

  • The liquid biopsy segment is expected to grow at the highest CAGR during the projected period on account of wide usage
  • The kits and consumables segment accounted for the largest market share in 2022, which is mainly driven by cost-effectiveness and higher performance.
  • The breast cancer segment held a significant market revenue share in 2022, mainly due to its high prevalence rate
  • North America region dominated the market with a majority share in 2022, owing to exponential growth in the technology and advanced healthcare system
  • The global key market players include: Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc

Polaris Market Research has segmented the cancer biopsy market report based on type, product type, application, and region:

Cancer Biopsy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Liquid, Biopsy
  • Tissue Biopsy
  • Others

Cancer Biopsy, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Kits and Consumables
  • Instruments
  • Services

Cancer Biopsy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Cervical Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Cancer Biopsy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Biopsy Market Insights

  • 4.1. Cancer Biopsy Market - Application Snapshot
  • 4.2. Cancer Biopsy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in cancer cases is projected to spur the product demand
      • 4.2.1.2. Advancements in molecular diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs associated with cancer biopsy tests
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cancer Biopsy Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer Biopsy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Liquid, Biopsy
    • 5.3.1. Global Cancer Biopsy Market, by Liquid, Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.4. Tissue Biopsy
    • 5.4.1. Global Cancer Biopsy Market, by Tissue Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Cancer Biopsy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Biopsy Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 6.3. Kits and Consumables
    • 6.3.1. Global Cancer Biopsy Market, by Kits and Consumables, by Region, 2019-2032 (USD Billion)
  • 6.4. Instruments
    • 6.4.1. Global Cancer Biopsy Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global Cancer Biopsy Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Cancer Biopsy Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Breast Cancer
    • 7.3.1. Global Cancer Biopsy Market, by Breast Cancer, By Region, 2019-2032 (USD Billion)
  • 7.4. Cervical Cancer
    • 7.4.1. Global Cancer Biopsy Market, by Cervical Cancer, By Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Cancer Biopsy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Cancer Biopsy Market, by Colorectal Cancer, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Cancer Biopsy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Cancer Biopsy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cancer Biopsy Market - North America
    • 8.3.1. North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4. Cancer Biopsy Market - U.S.
      • 8.3.4.1. U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5. Cancer Biopsy Market - Canada
      • 8.3.5.1. Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4. Cancer Biopsy Market - Europe
    • 8.4.1. Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4. Cancer Biopsy Market - UK
      • 8.4.4.1. UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5. Cancer Biopsy Market - France
      • 8.4.5.1. France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6. Cancer Biopsy Market - Germany
      • 8.4.6.1. Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7. Cancer Biopsy Market - Italy
      • 8.4.7.1. Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8. Cancer Biopsy Market - Spain
      • 8.4.8.1. Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9. Cancer Biopsy Market - Netherlands
      • 8.4.9.1. Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10. Cancer Biopsy Market - Russia
      • 8.4.10.1. Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5. Cancer Biopsy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4. Cancer Biopsy Market - China
      • 8.5.4.1. China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5. Cancer Biopsy Market - India
      • 8.5.5.1. India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6. Cancer Biopsy Market - Malaysia
      • 8.5.6.1. Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7. Cancer Biopsy Market - Japan
      • 8.5.7.1. Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8. Cancer Biopsy Market - Indonesia
      • 8.5.8.1. Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9. Cancer Biopsy Market - South Korea
      • 8.5.9.1. South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6. Cancer Biopsy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4. Cancer Biopsy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5. Cancer Biopsy Market - UAE
      • 8.6.5.1. UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6. Cancer Biopsy Market - Israel
      • 8.6.6.1. Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7. Cancer Biopsy Market - South Africa
      • 8.6.7.1. South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7. Cancer Biopsy Market - Latin America
    • 8.7.1. Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4. Cancer Biopsy Market - Mexico
      • 8.7.4.1. Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5. Cancer Biopsy Market - Brazil
      • 8.7.5.1. Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6. Cancer Biopsy Market - Argentina
      • 8.7.6.1. Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Rad Laboratories, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Koninklijke Philips N.V.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeoGenomics, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. QIAGEN N.V.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Siemens Healthineers AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sysmex Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Veracyte, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development